![\"\"\/](\"https:\/\/lh7-rt.googleusercontent.com\/docsz\/AD_4nXd_5I-Pgu1H2Z4xq57KWiLdwQTRM6WwrvV5Y8TQ7fmSZKVM0panqGqiXAI_ged6Q7D9HN1Eareyn7CoLIcMJjkN3s2joSQtJgPbmv5VW8XIAN99YXeANWtKLH0nVnr0ImCEFEMd5Q?key=gM_DZmo8j_EzMUmXhbenF0QK\")
Eagle-eyed readers will notice an apparent drop in submissions during the early months of 2025. Closer inspection reveals that the decrease is specific to the Research Square preprint server (which is owned by Springer Nature). Daily postings dropped from about 236 per day in the first quarter of 2024 (Q1) to fewer than 80 per day in 2025. On average, this represents a 66.6% decrease from Q1 2024 to Q1 2025. Over the same time period, bioRxiv submissions increased moderately, by an average of 9.8%.<\/p>\n\n\n\n A representative from Springer Nature confirms that \u201cthe recent decrease in preprints is due to a temporary reduction in our screening capacity.\u201d They also report that \u201cour team is working to increase capacity so we can resume previous posting volumes\u201d and additionally confirm that \u201cwe did experience a backlog, but this is steadily improving.\u201d Additional information about Research Square screening processes is available at https:\/\/www.researchsquare.com\/legal\/editorial<\/a>. Screening verifies the presence of statements about ethics and conflicts of interest, along with the lack of patient identifiers and pseudoscientific claims.<\/p>\n\n\n\n Researchers should be aware that they may experience a delay in posting of their preprints at Research Square. ASAPbio will continue to monitor the posting volume and report back when there are further developments. Have a recent preprinting experience you think would be useful for the community to know about?\u00a0<\/p>\n\n\n\n![\"Two](\"https:\/\/asapbio.org\/wp-content\/uploads\/2025\/04\/graphs.png\")